Oral lipid-based nanoformulation of tafenoquine enhanced bioavailability and blood stage antimalarial efficacy and led to a reduction in human red blood cell loss in mice

di Melariri, Paula, Kalombo, Lonji, Nkuna, Patric, Dube, Admire, Hayeshi, Rose, Ogutu, Benhards, Gibhard, Liezl, deKock, Carmen, Smith, Peter, Wiesner, Lubbe, Swai, Hulda
Pubblicato in Int J Nanomedicine (2015)

Spray-Dried, Nanoencapsulated, Multi-Drug Anti-Tuberculosis Therapy Aimed at Once Weekly Administration for the Duration of Treatment

di Kalombo, Lonji, Lemmer, Yolandy, Semete-Makokotlela, Boitumelo, Ramalapa, Bathabile, Nkuna, Patric, Booysen, Laetitia L.L.I.J., Naidoo, Saloshnee, Hayeshi, Rose, Verschoor, Jan A., Swai, Hulda S.
Pubblicato in Nanomaterials (Basel) (2019)